Phathom Pharmaceuticals, Inc. (PHAT)

11.07 -0.39 (-3.40%) USD  |  NASDAQ  |  Mar 03, 16:00
11.07 0.00 (0.00%) After-Hours: 20:00
More

Phathom Pharmaceuticals Stock Based Compensation (5 Year Growth)

Stock Based Compensation (5 Year Growth) Chart

View Stock Based Compensation (5 Year Growth) for PHAT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (5 Year Growth) Range, Past 5 Years

View Stock Based Compensation (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (5 Year Growth) Benchmarks

View Stock Based Compensation (5 Year Growth) Benchmarks
Start Trial
MannKind Corp. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade
Ligand Pharmaceuticals, Inc. Upgrade
Ocugen, Inc. Upgrade
Rhythm Pharmaceuticals, Inc. Upgrade